- Total income
- Administrative expenses
- Fundraising expenses
- Program percentage
- Accessible financial information
- Donor communication
Susan G. Komen For the Cure reported a total income of $250,276,362 in its 2015 financial statement, which is lower than its reported income of $287,409,269 in 2014. It appears as if the organization's income is on a downward trend, with 2013 income totaling $325,202,243 and 2012 income totaling $398,964,568.
According to Susan G. Komen For the Cure's 2015 financial statement, $20,719,400 of its income was spent on administrative expenses. In 2014, Nancy Brinker, the organization's Global Strategy Chair, received a salary of $646,000 and CEO Dr. Judith Salerno received a salary of $475,000.
In 2015, Susan G. Komen For the Cure spent $31,992,548 on fundraising, which is about 10 percent of the organization's annual revenue.
On average, Susan G. Komen For the Cure uses about 80 to 86 percent of its income to support its program. The primary focus of the charity is education, with research being the secondary focus.
Accessible Financial Information
Susan G. Komen For the Cure has published its annual reports for 2009 to 2015, its audited financial statements for 2010 to 2015, and its Form 990s for 2010 to 2015 on the Financial Information page of its website. These reports are comprehensive.
In addition to receiving documentation of their tax-deductible gifts to Susan G. Komen For the Cure, all donors will receive the charity's national newsletter, which highlights current education campaigns and research. Donors have also reported receiving periodic communication from the charity requesting further contributions or alerting them about events in their area.
The most prestigious award given to Susan G. Komen For the Cure is the CEO Cancer Gold StandardTM accreditation, which has been annually awarded to the organization since 2010. This award recognizes the organization's focus on education and prevention in its fight against breast cancer.